GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allied Healthcare Products Inc (OTCPK:AHPIQ) » Definitions » EBITDA
中文

Allied Healthcare Products (Allied Healthcare Products) EBITDA

: $-4.12 Mil (TTM As of Jun. 2022)
View and export this data going back to 1992. Start your Free Trial

Allied Healthcare Products's EBITDA for the three months ended in Jun. 2022 was $-1.16 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 was $-4.12 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

Allied Healthcare Products's EBITDA per Share for the three months ended in Jun. 2022 was $-0.29. Its EBITDA per share for the trailing twelve months (TTM) ended in Jun. 2022 was $-1.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.


Allied Healthcare Products EBITDA Historical Data

The historical data trend for Allied Healthcare Products's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied Healthcare Products Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
EBITDA
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.06 -1.20 -2.46 2.46 -4.12

Allied Healthcare Products Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.78 -0.84 -1.01 -1.12 -1.16

Competitive Comparison

For the Medical Devices subindustry, Allied Healthcare Products's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allied Healthcare Products EV-to-EBITDA Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Allied Healthcare Products's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Allied Healthcare Products's EV-to-EBITDA falls into.


Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Allied Healthcare Products's EBITDA for the fiscal year that ended in Jun. 2022 is calculated as

Allied Healthcare Products's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Jun. 2022, Allied Healthcare Products's EBITDA was $-4.12 Mil.

Allied Healthcare Products's EBITDA for the quarter that ended in Jun. 2022 is calculated as

Allied Healthcare Products's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Jun. 2022, Allied Healthcare Products's EBITDA was $-1.16 Mil.

EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Allied Healthcare Products  (OTCPK:AHPIQ) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Allied Healthcare Products EBITDA Related Terms

Thank you for viewing the detailed overview of Allied Healthcare Products's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Allied Healthcare Products (Allied Healthcare Products) Business Description

Traded in Other Exchanges
N/A
Address
1720 Sublette Avenue, Saint Louis, MO, USA, 63110
Allied Healthcare Products Inc manufactures a variety of respiratory products used in the healthcare industry in a wide range of hospital and alternate site settings, including sub-acute care facilities, home health care, and emergency medical care. The product line of the company includes respiratory anesthesia products, home respiratory care products, medical gas system construction products, medical gas system regulation devices, disposable oxygen, and specialty gas cylinders, portable suction equipment, trauma, and patient handling products, respiratory products, and others. The company markets its products under various brand names Timeter, Carbolime, Litholyme, Schuco, Chemetron, Oxequip, Lif-O-Gen, Gomco, and others.
Executives
John D Weil director, 10 percent owner 10 S. BROADWAY, SUITE 2000, ST LOUIS MO 63102
Susan M Deuser director 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Kevin D Kroupa officer: Vice President of Operations 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Earl R Refsland director, officer: President and CEO 1720 SUBLETT AVENUE, ST. LOUIS MO 63110
Joseph F Ondrus officer: Vice President of Operations 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Andrew Riley officer: VP of Operations 1720 SUBLETTE AVE., ST. LOUIS MO 63110
William A Peck director 35 CROSBY DRIVE, BEDFORD MA 01730
Daniel C Dunn officer: VP - Finance and CFO 1720 SUBLETTE AVE, ST. LOUIS MO 63110
Eldon P Rosentrater officer: VP - Administration 1720 SUBLETTE AVE, ST. LOUIS MO 63110
Root Joseph Ernest Jr director HAYNES BEFFEL & WOLFELD LLP, 751 KELLY STREET, HALF MOON BAY CA 94019
Robert Bradley Harris officer: Vice President of Operations 15 RIVER RIDGE TRAIL, ORMOND BEACH FL 32174
Judy T Graves director 13317 WESTERMAN RD, ST LOUIS MO 63122
Hickey James B Jr director 4608 EDINA BLVD, EDINA MN 55424
Richard A Setzer officer: VICE PRESIDENT SALES & MKTG 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Brent D Baird director 1350 ONE M&T PLAZA, BUFFALO NY 14203-2396